TenderlineUK
Procurement Intelligence
Search
Find a TenderAwarded
Published 28 Apr 2021, 16:29 BST

Official UK procurement notice

National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England

Official notice

Authority: The NHS Commissioning Board (operating under the name of NHS England) (NHS & healthcare)

Framework agreement49 lotsGoodsOpen procedureSME suitable
Sectors: Medical Devices & Pharma (33) Delivery: UK
Framework ceiling (notional)Value not publishedframework ceiling, not attributable revenue
Awarded 18 Mar 2021
Lots 49see the lot list below

What is being bought49 lots · detail below

Published requirement description

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. Period of framework agreement: 1 April 2021 to 31 March 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.

CPV: Pharmaceutical products

How this framework works

From the published notice
Bids received
4 bids on the busiest of 25 lots · 4 suppliers appointed

Lots and requirements (49)Procurement structure

25 of 49 loaded on this page

Showing the first 25 of 49 published lots; the full list is in the JSON and Markdown mirrors of this notice. 49 lots · no lot values published.

Lot #1Atezolizumab - Lot 1Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above.
33600000 Pharmaceutical products
Lot #2Bevacizumab (Avastin) - Lot 2Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above.
33600000 Pharmaceutical products
Lot #3Bevacizumab (Zirabev) - Lot 3Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above.
33600000 Pharmaceutical products
Lot #4Bevacizumab (Aybintio) - Lot 4Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above.
33600000 Pharmaceutical products
Lot #5Bleomycin - Lot 5Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above.
33600000 Pharmaceutical products
Lot #6Bortezomib - Lot 6Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above.
33600000 Pharmaceutical products
Lot #7Carboplatin - Lot 7Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above.
33600000 Pharmaceutical products
Lot #8Cetuximab - Lot 8Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above.
33600000 Pharmaceutical products
Lot #9Cisplatin - Lot 9Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above.
33600000 Pharmaceutical products
Lot #10Cyclophosphamide Syringes - Lot 10Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above.
33600000 Pharmaceutical products
Lot #11Cyclophosphamide Bags - Lot 11Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above.
33600000 Pharmaceutical products
Lot #12Cytarabine - Lot 12Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above.
33600000 Pharmaceutical products
Lot #13Docetaxel - Lot 13Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above
33600000 Pharmaceutical products
Lot #14Doxorubicin - Lot 14Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above
33600000 Pharmaceutical products
Lot #15Epirubicin - Lot 15Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above.
33600000 Pharmaceutical products
Lot #16Fludarabine Syringes - Lot 16Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above.
33600000 Pharmaceutical products
Lot #17Fludarabine Bags - Lot 17Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above.
33600000 Pharmaceutical products
Lot #18Fluorouracil Syringes - Lot 18Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above.
33600000 Pharmaceutical products
Lot #19Fluorouracil Bags - Lot 19Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above.
33600000 Pharmaceutical products
Lot #20Fluorouracil in Elastomeric Devices (Folfusor SV0.5) - Lot 20Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above.
33600000 Pharmaceutical products
Lot #21Fluorouracil in Elastomeric Devices (Folfusor SV2.5) - Lot 21Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above.
33600000 Pharmaceutical products
Lot #22Fluorouracil in Elastomeric Devices (Folfusor LV1.5) - Lot 22Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above.
33600000 Pharmaceutical products
Lot #23Fluorouracil in Elastomeric Devices (Folfusor LV5) - Lot 23Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above.
33600000 Pharmaceutical products
Lot #24Fluorouracil in Elastomeric Devices (Autofuser 2.5ml/hr) - Lot 24Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above.
33600000 Pharmaceutical products
Lot #25Fluorouracil in Elastomeric Devices (Autofuser 2ml/hr) - Lot 25Awarded

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.

Delivery: UK · ITT lists Purchasing Points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors and agents working on behalf of the above.
33600000 Pharmaceutical products

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
What this means for your bid
  • “National Framework Agreement for the supply of Aseptically Prepared…” is a framework: the contest is a place on its panel, not a single contract.

Procedure terms & legal framework

From the official record
Procedure method
Open procedure
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use this agreement
Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
28 Apr 2021, 16:29 BST
Last source update
28 Apr 2021, 16:29 BST
FTS notice number
2021/S 000-009177
Classification (CPV)
Pharmaceutical products
Delivery area
UK
Official registry OCID
ocds-h6vhtk-02ab4a Find a Tender

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Suppliers appointed 4admitted to the panel · see the list ↓
Bids received 41 from SMEs · busiest of 25 lots
Contracts signed 20latest 18 Mar 2021

93 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.

Contracts

All 20 of these contracts carry the same published figure, £1, the framework's maximum for the whole notice, not each contract's own value. They are not eleven separate sums.

  • Contract 009177-2021-1

    Signed
    18 Mar 2021
    Value
    ceiling above
    Status
    active

  • Contract 009177-2021-10

    Signed
    18 Mar 2021
    Value
    ceiling above
    Status
    active

  • Contract 009177-2021-11

    Signed
    18 Mar 2021
    Value
    ceiling above
    Status
    active

  • Contract 009177-2021-12

    Signed
    18 Mar 2021
    Value
    ceiling above
    Status
    active

  • Contract 009177-2021-13

    Signed
    18 Mar 2021
    Value
    ceiling above
    Status
    active

  • Contract 009177-2021-14

    Signed
    18 Mar 2021
    Value
    ceiling above
    Status
    active

  • Contract 009177-2021-15

    Signed
    18 Mar 2021
    Value
    ceiling above
    Status
    active

  • Contract 009177-2021-16

    Signed
    18 Mar 2021
    Value
    ceiling above
    Status
    active

  • Contract 009177-2021-17

    Signed
    18 Mar 2021
    Value
    ceiling above
    Status
    active

  • Contract 009177-2021-18

    Signed
    18 Mar 2021
    Value
    ceiling above
    Status
    active

  • Contract 009177-2021-19

    Signed
    18 Mar 2021
    Value
    ceiling above
    Status
    active

  • Contract 009177-2021-2

    Signed
    18 Mar 2021
    Value
    ceiling above
    Status
    active

  • Contract 009177-2021-20

    Signed
    18 Mar 2021
    Value
    ceiling above
    Status
    active

  • Contract 009177-2021-21

    Signed
    18 Mar 2021
    Value
    ceiling above
    Status
    active

  • Contract 009177-2021-22

    Signed
    18 Mar 2021
    Value
    ceiling above
    Status
    active

  • Contract 009177-2021-23

    Signed
    18 Mar 2021
    Value
    ceiling above
    Status
    active

  • Contract 009177-2021-24

    Signed
    18 Mar 2021
    Value
    ceiling above
    Status
    active

  • Contract 009177-2021-25

    Signed
    18 Mar 2021
    Value
    ceiling above
    Status
    active

  • Contract 009177-2021-26

    Signed
    18 Mar 2021
    Value
    ceiling above
    Status
    active

  • Contract 009177-2021-27

    Signed
    18 Mar 2021
    Value
    ceiling above
    Status
    active

Bid statistics published by the authority

LotBidsSMEVCSEValid bid range
1 · Atezolizumab - Lot 14bids · 4 electronic · 4 from abroad1——
2 · Bevacizumab (Avastin) - Lot 24bids · 4 electronic · 4 from abroad1——
3 · Bevacizumab (Zirabev) - Lot 33bids · 3 electronic · 3 from abroad1——
4 · Bevacizumab (Aybintio) - Lot 43bids · 3 electronic · 3 from abroad1——
5 · Bleomycin - Lot 51bids · 1 electronic · 1 from abroad1——
6 · Bortezomib - Lot 64bids · 4 electronic · 4 from abroad1——
7 · Carboplatin - Lot 74bids · 4 electronic · 4 from abroad1——
8 · Cetuximab - Lot 83bids · 3 electronic · 3 from abroad1——
9 · Cisplatin - Lot 93bids · 3 electronic · 3 from abroad1——
10 · Cyclophosphamide Syringes - Lot 103bids · 3 electronic · 3 from abroad1——
11 · Cyclophosphamide Bags - Lot 113bids · 3 electronic · 3 from abroad1——
12 · Cytarabine - Lot 123bids · 3 electronic · 3 from abroad1——
13 · Docetaxel - Lot 132bids · 2 electronic · 2 from abroad0——
14 · Doxorubicin - Lot 143bids · 3 electronic · 3 from abroad1——
15 · Epirubicin - Lot 154bids · 4 electronic · 4 from abroad1——
16 · Fludarabine Syringes - Lot 161bids · 1 electronic · 1 from abroad1——
17 · Fludarabine Bags - Lot 171bids · 1 electronic · 1 from abroad1——
18 · Fluorouracil Syringes - Lot 183bids · 3 electronic · 3 from abroad1——
19 · Fluorouracil Bags - Lot 193bids · 3 electronic · 3 from abroad1——
20 · Fluorouracil in Elastomeric Devices (Folfusor SV0.5) - Lot 203bids · 3 electronic · 3 from abroad1——
21 · Fluorouracil in Elastomeric Devices (Folfusor SV2.5) - Lot 213bids · 3 electronic · 3 from abroad1——
22 · Fluorouracil in Elastomeric Devices (Folfusor LV1.5) - Lot 223bids · 3 electronic · 3 from abroad1——
23 · Fluorouracil in Elastomeric Devices (Folfusor LV5) - Lot 233bids · 3 electronic · 3 from abroad1——
24 · Fluorouracil in Elastomeric Devices (Autofuser 2.5ml/hr) - Lot 241bids · 1 electronic · 1 from abroad0——
25 · Fluorouracil in Elastomeric Devices (Autofuser 2ml/hr) - Lot 251bids · 1 electronic · 1 from abroad0——

Contracting authority & participating public bodies

The NHS Commissioning Board (operating under the name of NHS England)

Contracting authorityNHS & healthcareMinistry or any other national or federal authority, including their regional or local subdivisionsHealth 2nd Floor, Rutland House, Runcorn, UK, WA7 2ESContact name, email

Dispute resolution & review bodies

  • The High CourtReview body LondonContact email

Framework contractors & participating bidders

4 commercial parties on the notice
  • Baxter Healthcare LtdFramework contractor Wallingford Road, Compton, Newbury, Berkshire, RG20 7QW, Newbury, UK, RG20 7QW
  • ITH PharmaFramework contractor Unit 4, Premier Park, London, London, UK, NW10 7NZ
  • Qualasept Ltd t/a Bath ASUFramework contractor 3 Corsham Science Park, Park Lane, Corsham, Wiltshire, Corsham, UK, SN13 9FU
  • Quantum Aseptic ServicesFramework contractor Quantum House, Hobson Industrial Estate, Burnopfield, Co.Durham, Burnopfield, UK, NE16 6EA

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.